In Vivo Imaging of Multidrug Resistance Using a Third Generation MDR1 Inhibitor

Bioconjugate Chemistry - Tập 25 Số 6 - Trang 1137-1142 - 2014
Melissa M. Sprachman1, Ashley M. Laughney2, Rainer H. Köhler2, Ralph Weissleder1,3
1Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, Massachusetts 02114, United States
2Center#R#for Systems Biology, Massachusetts General Hospital, 185 Cambridge#R#Street, CPZN 5206, Boston, Massachusetts 02114, United States
3Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, United States

Tóm tắt

Từ khóa


Tài liệu tham khảo

Borst P., 2013, J. Clin. Invest., 123, 4131, 10.1172/JCI70430

Kunjachan S., 2013, Adv. Drug Delivery Rev., 65, 1852, 10.1016/j.addr.2013.09.018

Misaka S., 2013, Curr. Opin. Pharmacol., 13, 847, 10.1016/j.coph.2013.08.010

Deeley R. G., 2006, Physiol. Rev., 86, 849, 10.1152/physrev.00035.2005

Colabufo N. A., 2010, J. Med. Chem., 53, 1883, 10.1021/jm900743c

Nobili S., 2012, Med. Res. Rev., 32, 1220, 10.1002/med.20239

Aller S., 2009, Science, 323, 1718, 10.1126/science.1168750

Mechetner E., 1998, Clin. Cancer Res., 4, 389

Longley D. B., 2005, J. Pathol., 205, 275, 10.1002/path.1706

Kwak J. O., 2010, Eur. J. Pharmacol., 627, 92, 10.1016/j.ejphar.2009.11.008

McDevitt C. A., 2007, Pharmacol. Ther., 113, 429, 10.1016/j.pharmthera.2006.10.003

Yang K., 2008, BioScience Trends, 2, 137

Zhang L., 2010, ChemMedChem, 5, 811, 10.1002/cmdc.201000006

Nieto Montesinos R., 2012, J. Controlled Release, 161, 50, 10.1016/j.jconrel.2012.04.034

Raderer M., 1993, Cancer, 72, 3553, 10.1002/1097-0142(19931215)72:12<3553::AID-CNCR2820721203>3.0.CO;2-B

Krishna R., 2000, Eur. J. Pharm. Sci., 11, 265, 10.1016/S0928-0987(00)00114-7

Chen Z., 2012, Nature, 483, 613, 10.1038/nature10937

Saneja A., 2014, Expert Opin. Drug Delivery, 11, 121, 10.1517/17425247.2014.865014

Budin G., 2011, Angew. Chem., Int. Ed. Engl., 50, 9378, 10.1002/anie.201103273

Yang K. S., 2012, Angew. Chem., Int. Ed. Engl., 51, 6598, 10.1002/anie.201200994

Kim E., 2013, PLoS One, 8, e81275, 10.1371/journal.pone.0081275

Thurber G. M., 2013, Nat. Commun., 4, 1504, 10.1038/ncomms2506

Globisch C., 2006, Bioorg. Med. Chem., 14, 1588, 10.1016/j.bmc.2005.10.058

Chang C., 2006, Drug Metab. Dispos., 34, 1976, 10.1124/dmd.106.012351

Crivellato E., 2002, J. Histochem. Cytochem., 50, 731, 10.1177/002215540205000514

Bang, K. C., Cha, M. Y., Ahn, Y. G., Ham, Y. J., Kim, M. S., and Lee, G. S. (2005) P-Glycoprotein Inhibitor, Method for Preparing the Same and Pharmaceutical Composition Comprising the Same, PCT Int. Appl. WO 2005/033097 A1.

Pajeva I. K., 2013, ChemMedChem, 8, 1701, 10.1002/cmdc.201200491

Rottenberg S., 2008, Proc. Natl. Acad. Sci. U.S.A., 105, 17079, 10.1073/pnas.0806092105

Reiner T., 2012, Neoplasia, 14, 169, 10.1593/neo.12414

Dizdarevic S., 2011, Cancer Imaging, 11, 1, 10.1102/1470-7330.2011.0001

Lebedeva I. V., 2011, PLoS One, 6, e22429, 10.1371/journal.pone.0022429

Zolnerciks J. K., 2011, J. Pharm. Sci., 100, 3055, 10.1002/jps.22566

Strouse J. J., 2013, Anal. Biochem., 437, 77, 10.1016/j.ab.2013.02.018